Fresh Pharm...A Medication Update
This is a hybrid educational activity. This is a full day, interprofessional, CME accredited conference where we share all that is fresh and new in the realm of medications. We present exciting pharmacy topics and clinical practice guideline updates that are applicable to acute, ambulatory, and community practitioners that care for adults and children. Providers, nurses, pharmacists and more will benefit from an enriching day of education.
Target Audience
Learning Objectives
At the completion of this course, the participant should be able to:
- discuss indications, mechanisms of action, dosing, and side effects of newly approved medications
- utilize medications to optimize care for patients with liver disease.
- describe pharmacologic updates and safety strategies rapid sequence intubation, paralytics, push dose pressors and poisons
- identify newly approved vaccination and treatment guidelines for children and adults with RSV
- review hot topics in the management of gender affirming care.
- discuss cutting edge updates in atrial fibrillation for outpatients and inpatients
- delineate drug therapy for fungal infections
- evaluate 2024 prevention and treatment strategies for COVID-19
- highlight novel treatments and state of the art technology for patients with diabetes
Accreditation
In support of improving patient care, Geisinger Commonwealth School of Medicine is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
Credit Designation
Geisinger Commonwealth School of Medicine designates this live activity for a maximum of 6 AMA PRA Category 1 Credit(s)™. Physicians should only claim credit commensurate with the extent of their participation in the educational activity.
Geisinger Commonwealth School of Medicine designates this live activity for 6 contact hours for nurses. Nurses should only claim credit commensurate with the extent of their participation in the educational activity.
This live activity is approved for 6 contact hours (6 CEUs) of continuing pharmacy education credit JA0008072-0000-24-004-L01-P and JA0008072-000-24-004-L01-T.
Geisinger Commonwealth School of Medicine has been authorized by the American Academy of PAs (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with AAPA CME Criteria. This activity is designated for 6 AAPA Category 1 CME credits. PAs should only claim credit commensurate with the extent of their participation.
This activity was planned by and for the healthcare team, and learners will receive 6 Interprofessional Continuing Education (IPCE) credits for learning and change.
Disclosure Policy
Faculty and all others who have the ability to control the content of continuing education activity sponsored by Geisinger Commonwealth School of Medicine must disclose to the program audience whether they do or do not have any real or apparent conflict(s) of interest or other relationships related to the content of their presentation(s).
Available Credit
- 6.00 AAPA Category I CME
- 6.00 ACPE
- 6.00 ACPE Tech
- 6.00 AMA PRA Category 1 Credit™
- 6.00 ANCC
- 6.00 Participation Credit